EPSTEIN DAVID R purchased 66.7% of their position (10K shares) of AGOMAB THERAPEUTICS NV on the open market
Open‑market purchase worth $88.8K — a major conviction buy. The strongest form of insider conviction signal.
P · 2 purchases
Filed: 10/22/2026ACC: 0001445826-26-000015
+10K
Net shares
Net buyer
$88.8K
Total acquired
2
Open market trades
2B · 0S
2
Total transactions
10K acquired
Non-Derivative Transactions2
Common shares
Direct
Shares
+5K
Price / share
$8.86
Trade value
$44.30K
% of position
33.3%
10/21/2026
15K→20K
Common shares
Direct
Shares
+5K
Price / share
$8.90
Trade value
$44.50K
% of position
25.0%
10/21/2026
20K→25K
Total
Net shares
+10K
Net value
$88.80K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common shares Direct | 10/21/2026 | P · Purchase | +5K | $8.86 | $44.30K | 33.3% | 15K | 20K |
| Common shares Direct | 10/21/2026 | P · Purchase | +5K | $8.90 | $44.50K | 25.0% | 20K | 25K |
| Total | +10K | $88.80K | ||||||
Derivative Transactions0
No derivative transactions reported